30165

チロフィバン

≥98.5% (HPLC)

• 別名: (2S)-2-(ブチルスルホニルアミノ)3-{4-[4-(4-ピペリジル)ブトキシ}フェニル プロパン酸, N-(ブチルスルホニル)-O-[4-(4-ピペリジニル)ブチル]-L-チロシン
• 実験式（ヒル表記法）: C₂₂H₃₆N₂O₅S
• CAS番号: 144494-65-5
• 分子量: 440.60
• UNSPSC Code: 12352106
• NACRES: NA.25
• PubChem Substance ID: 329753339
• MDL number: MFCD05237246
• Beilstein/REAXYS Number: 6182267

特性

• Quality Segment: 100
• assay: ≥98.5% (HPLC)
• form: powder
• SMILES string: CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O
• InChI: 1S/C22H36N2O5S/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26)/t21-/m0/s1
• InChI key: COKMIXFXJJXBQG-NRFANRHFSA-N
• Gene Information: human ... ITGA2B(3674), ITGB3(3690)

詳細

Application

• The efficacy and safety of continuous intravenous tirofiban for acute ischemic stroke patients treated by endovascular therapy: a meta-analysis.: This meta-analysis assesses the safety and efficacy of continuous intravenous tirofiban in patients undergoing endovascular therapy for acute ischemic stroke, showing promising results for improved outcomes (Wang et al., 2024).


• Initial Experience with a New Self-Expanding Open-Cell Stent System with Antithrombotic Hydrophilic Polymer Coating (pEGASUS Stent) in the Treatment of Wide-Necked Intracranial Aneurysms.: This study reports on the initial use of a new stent system coated with tirofiban in treating intracranial aneurysms, demonstrating enhanced safety and efficacy (Boxberg et al., 2024).

Packaging

底の開いたガラス瓶内容物は内部に挿入され接着された円錐部に入っています。

安全性情報

• pictograms: GHS07
• signalword: Warning
• hcodes: H315,H319,H335
• pcodes: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• target_organs: Respiratory system
• 保管分類: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: dust mask type N95 (US), Eyeshields, Gloves